These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 14507264)

  • 1. Absence of activation of CMV by blood transfusion to HIV-infected, CMV-seropositive patients.
    Drew WL; Chou S; Mohr BA; Assmann SF; Miner RC; Laycock ME; Busch MP;
    Transfusion; 2003 Oct; 43(10):1351-7. PubMed ID: 14507264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency and duration of plasma CMV viremia in seroconverting blood donors and recipients.
    Drew WL; Tegtmeier G; Alter HJ; Laycock ME; Miner RC; Busch MP
    Transfusion; 2003 Mar; 43(3):309-13. PubMed ID: 12675714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukocyte-reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trial.
    Collier AC; Kalish LA; Busch MP; Gernsheimer T; Assmann SF; Lane TA; Asmuth DM; Lederman MM; Murphy EL; Kumar P; Kelley M; Flanigan TP; McMahon DK; Sacks HS; Kennedy MS; Holland PV;
    JAMA; 2001 Mar; 285(12):1592-601. PubMed ID: 11268267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qualitative and quantitative PCR measures of cytomegalovirus in patients with advanced HIV infection who require transfusions.
    Para MF; Kalish LA; Collier AC; Pollard RB; Kumar PN; Mintz L; Wallach FR; Drew WL;
    J Acquir Immune Defic Syndr; 2001 Apr; 26(4):320-5. PubMed ID: 11317072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfusion-transmitted cytomegalovirus: behaviour of cell-free virus during blood component processing. A study on the safety of labile blood components in Switzerland.
    Voruz S; Gowland P; Eyer C; Widmer N; Abonnenc M; Prudent M; Masouridi-Levrat S; Duchosal MA; Niederhauser C
    Blood Transfus; 2020 Nov; 18(6):446-453. PubMed ID: 32203012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfusion-transmitted cytomegalovirus (CMV) infections in a murine model: characterization of CMV-infected donor mice.
    Roback JD; Su L; Newman JL; Saakadze N; Lezhava LJ; Hillyer CD
    Transfusion; 2006 Jun; 46(6):889-95. PubMed ID: 16734804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An assessment of donor-to-recipient transmission patterns of human cytomegalovirus by analysis of viral genomic variants.
    Manuel O; Pang XL; Humar A; Kumar D; Doucette K; Preiksaitis JK
    J Infect Dis; 2009 Jun; 199(11):1621-8. PubMed ID: 19385736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of cytomegalovirus DNA in plasma samples of blood donors in connection with seroconversion.
    Ziemann M; Krueger S; Maier AB; Unmack A; Goerg S; Hennig H
    Transfusion; 2007 Nov; 47(11):1972-83. PubMed ID: 17958525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlates of change in cytomegalovirus viremia in patients with advanced human immunodeficiency virus infection who require transfusion.
    Para MF; Kalish LA; Collier AC; Murphy EL; Drew WL;
    J Infect Dis; 2001 Jun; 183(11):1673-7. PubMed ID: 11343218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct assessment of cytomegalovirus transfusion-transmitted risks after universal leukoreduction.
    Wu Y; Zou S; Cable R; Dorsey K; Tang Y; Hapip CA; Melmed R; Trouern-Trend J; Wang JH; Champion M; Fang C; Dodd R
    Transfusion; 2010 Apr; 50(4):776-86. PubMed ID: 19912585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfusion and cytomegalovirus-associated AIDS-defining disease in hemophiliacs. Hemophilia Malignancy Study.
    Ragni MV; Triulzi DJ; Bass D; Duerstein S
    Transfusion; 1996 Aug; 36(8):681-4. PubMed ID: 8780661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of blood transfusion on the occurrence of pneumonitis in primary cytomegalovirus infection after liver transplantation.
    Mañez R; Kusne S; Martin M; Linden P; Irish W; Torre-Cisneros J; Kramer D; Ho M; Starzl TE
    Transfusion; 1993 Jul; 33(7):594-7. PubMed ID: 8392759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of donor cytomegalovirus DNA on transfusion strategies for at-risk patients.
    Ziemann M; Juhl D; Görg S; Hennig H
    Transfusion; 2013 Oct; 53(10):2183-9. PubMed ID: 23581526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of HBV and HCV, HTLV-I and -II, and human herpes virus-8 activation after allogeneic RBC transfusion in patients with advanced HIV-1 infection.
    Asmuth DM; Kalish LA; Laycock ME; Murphy EL; Mohr BA; Lee TH; Gallarda J; Giachetti C; Dollard SC; van der Horst CM; Grant RM; Busch MP;
    Transfusion; 2003 Apr; 43(4):451-8. PubMed ID: 12662277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusion-acquired cytomegalovirus infection in neonates. A prospective study.
    Preiksaitis JK; Brown L; McKenzie M
    Transfusion; 1988; 28(3):205-9. PubMed ID: 2835838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfusion-transmitted cytomegalovirus infections: significance and control.
    Tegtmeier GE
    Vox Sang; 1986; 51 Suppl 1():22-30. PubMed ID: 3017003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Number of RBC units and rate of transfusionto anemic HIV-positive patients assigned to receiveWBC-reduced or non-WBC-reduced RBCs: the viral activation transfusion study experience.
    Brecher ME; Triulzi DJ; Assmann SF;
    Transfusion; 2001 Jun; 41(6):794-8. PubMed ID: 11399822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is cytomegalovirus testing of blood products still needed for hematopoietic stem cell transplant recipients in the era of universal leukoreduction?
    Kekre N; Tokessy M; Mallick R; McDiarmid S; Huebsch L; Bredeson C; Allan D; Tay J; Tinmouth A; Sheppard D
    Biol Blood Marrow Transplant; 2013 Dec; 19(12):1719-24. PubMed ID: 24099958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photochemical treatment of platelet concentrates with amotosalen hydrochloride and ultraviolet A light inactivates free and latent cytomegalovirus in a murine transfusion model.
    Jordan CT; Saakadze N; Newman JL; Lezhava LJ; Maiers TT; Hillyer WM; Roback JD; Hillyer CD
    Transfusion; 2004 Aug; 44(8):1159-65. PubMed ID: 15265119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of transfusion-acquired CMV infection in seronegative solid-organ transplant recipients receiving non-WBC-reduced blood components not screened for CMV antibody (1984 to 1996): experience at a single Canadian center.
    Preiksaitis JK; Sandhu J; Strautman M
    Transfusion; 2002 Apr; 42(4):396-402. PubMed ID: 12076284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.